
Keywords: BEN; bendamustine; CI; combination index; CLB; chlorambucil; CLL; chronic lymphocytic leukemia; Cyclo; cyclophosphamide; dADO; deoxyadenosine; Del; deletion; DHE; dihydroethidium; DiOC6; 3,3â²-dihexyloxacarbocyanine iodide; DMSO; dimethyl sulfoxide; DR;